Medical Research Council

We welcome the National Action Plan for antimicrobial resistance (AMR) launched today by the Department of Health and Social Care. AMR is a large, complex problem that can’t be tackled by solely developing more antibiotics. Which is why through our continued investments we’re committed to supporting research across disciplines that looks at all aspects of the problem – from human behaviour and how we grow crops and rear animals for consumption, to how we manage the environment or use technology, clinical management strategies or challenge established cultural norms. This new national action plan will ensure the UK better restricts its use of antibiotics, antifungals, and antivirals – in both humans and animals – identify drug resistant infections before they emerge, and support industry in developing the next generation of treatments. Read the action plan ➡ https://lnkd.in/e9Xj6NxM

⭐ Programme Manager – Chemical Safety Assessment ⭐ National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs), London Work with scientists from the chemicals industries (including from agrochemicals and industrial chemicals, cosmetics and consumer products, pharmaceutical and contract research industries), academia and regulatory agencies to initiate, lead, support and deliver programmes of work that accelerate the 3Rs in the safety assessment of chemicals for the protection of human health and the environment. You will have access to a whole host of benefits from a defined benefit pension scheme and excellent holiday entitlement to access to employee shopping/travel discounts and salary sacrifice cycle to work scheme. https://lnkd.in/gTAfGTwc ⏰ Closing 2nd June 24 #biology #toxicology #medicalresearch #JobsAtUKRI

Do you have a keen interest in animals, and are you looking to start a career in scientific research? Take a look at our Animal Technician roles at Mary Lyon Centre at MRC Harwell: https://lnkd.in/ePXZrc47 #animalcare #researchjobs #JobsAtUKRI

Exciting news!✨ We are set to lead a new £8.2M Medical Research Council-funded medicine career development programme with Queen Mary University of London, University of Glasgow, The University of Manchester and industry partners. The fellowship programme is set to strengthen interactions between academia and industry to deliver world-class #medicine development. Programme lead, Professor Munir Pirmohamed said "This truly unique scheme offers an exciting opportunity for medically-qualified trainees at all levels, to undertake the best science in an environment that will foster joint working between universities and industry." Read more about the fellowship programme ➡️ https://brnw.ch/21wJovr AstraZeneca │ GSK │Optum │Faculty of Health & Life Sciences, University of Liverpool

“Our communities, my community, and other communities that are under-served, are still being disproportionately harmed by or dying from preventable health conditions. It's not acceptable." "Inclusivity is essential for equitable health research. This is a principle close to my heart personally. "When I was asked if I would like to be part of co-developing the MRC's public partnerships strategy it was an easy yes. It’s so important that diverse voices are included in initiatives that are driven by what I often refer to as ‘dominant’ institutions." Dr Nadine Fontaine-Palmer PhD, CEO of Mabadiliko CIC, shares a personal perspective of co-developing the MRC public partnerships strategy that aims to help improve how we involve people in research to benefit the health of everyone. https://orlo.uk/u0LUj wearevocal

New Research Alert!    A study in The Lancet by Clarke Ed and Dr. Ikechukwu Adigweme from our Vaccines and Immunity Theme explored the use of microarray patches to vaccinate children.    The comprehensive study which involved adults, toddlers and infants in The Gambia, found that, giving the measles and rubella vaccine by a microarray patch induced an immune response that was as strong as the response when the vaccine was given by conventional injection.    Read more: https://lnkd.in/dkgB4wmy

Do you have a PhD or equivalent in Biological Sciences and an understanding of gene structure and expertise in standard molecular biology techniques? Join us at Mary Lyon Centre at MRC Harwell as a Molecular Biologist 👩🔬 🔬 Find out more about about this great opportunity located in an expanding science and innovation park in Oxfordshire, in an internationally renowned centre at the forefront of genetics research - https://lnkd.in/gDrcZhnD #medicalresearch #researchjobs #biology #JobsAtUKRI

The Metascience Unit, jointly run by us and Department for Science, Innovation and Technology is working with Open Philanthropy to invest up to £5 million to fund metascience research grants that will improve our understanding of what works in the R&D system, as part of our evidence-based, data-driven approach to evolving the R&D landscape. We’re looking for proposals in the following areas: 🔵 Talent and professional development ➡️ including the effectiveness of interventions in training and skills, talent retention, stimulating entrepreneurship, or employer assessment methods in research contexts. 🔵 Allocation of research funding ➡️ including the impacts of different methods of peer review and different modes of funding (e.g. fellowships, research grants) on the distribution of research funds and scientific and career outcomes. 🔵 Modes of R&D delivery ➡️ including the efficacy of different institutional structures and sub-structures for conducting R&D. 🔵 Research integrity ➡️ including issues of reproducibility and the impact of interventions such as preregistration, open data, and reproducible code. 🔵 Improving the impact and dissemination of research outputs ➡️ including the role of technology transfer offices, different publication practices, conferences, and knowledge dissemination platforms. 🔵 Understanding impact ➡️ including improving the nuance with which we can define and measure the impact of research projects and programmes. 🔵 Understanding the impacts of AI ➡️ on the research and innovation ecosystem, including the funding and delivery of R&D. More information and how to apply: https://orlo.uk/BrOcJ

🚨 Exciting funding opportunity opening soon to use AstraZeneca’s world-leading facilities for High Throughput Screening. Join our webinar on 9 May to find out more and ask questions. Email highthroughputscreen@mrc.ukri.org to register. This is a unique opportunity for academic drug discovery projects allowing access to: 🔵 advanced compound management facilities 🔵 a large compound collection 🔵 advanced screening robotics 🔵 multiple state of the art assay platform technologies Funding priority in this round will be given to applications related to fibrosis or extracellular matrix targets. More ➡ https://lnkd.in/eCzp8yKh

Fancy some afternoon scrolling? I'd recommend having a peek at some of the amazing impacts coming out of MRC investments showcased here on this pretty shiny webpage. Lots of data and hard work went into this - great work Buddhini Samarasinghe!